Details for 2015802075

Up to date per 03.04.2026

Actions

Title / Product Name

1-[2-(AMINOMETHYL)BENZYL]-2-THIOXO-1,2,3,5-TETRAHYDRO-4H-PYRROLO[3,2-D]PYRIMIDIN-4-ONE ALS MYELOPEROXIDASE-HEMMER

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2015802075

EP Publication Number

3227294

E-Number

1166879

Language

PCT Number

EP15077998

Publication Date

11.10.2017 A

14.08.2019 B1

Registration Date

14.08.2019

AT Publication Date

15.08.2019

Application Date

30.11.2015

Registration Number

Priorities

01.12.2014

201462085722 P

27.05.2015

201562166808 P

IPC

C07D 487/04 20060101AFI20160613BHEP

Maximum Duration of Protection

30.11.2035

Owner

Astrazeneca AB 151 85 SödertäljeSE

Representative

Häupl & Ellmeyer KG PatentanwaltskanzleiMariahilfer Straße 50 (Kirchengasse 1)1070 WienAT

Inventor

INGHARDT, Tord BertilAstraZeneca S-431 83 MölndalSE

TOMKINSON, NicholasAstraZeneca Alderley Park Macclesfield Cheshire SK10 4TGGB

GAN, Li-MingAstraZeneca S-431 83 MölndalSE

STONEHOUSE, Jeffrey, Paulc/o AstraZeneca Intellectual Property AstraZeneca 35 Gatehouse Drive Waltham MA 02451US

JOHANNESSON, PetraAstraZeneca S-431 83 MölndalSE

JURVA, UlrikAstraZeneca S-431 83 MölndalSE

MICHAËLSSON, ErikAstraZeneca S-431 83 MölndalSE

LINDSTEDT-ALSTERMARK, Eva-LotteAstraZeneca S-431 83 MölndalSE

Information about Fees